Back to Search Start Over

Refractory Angina Pipeline Analysis Report 2022 - Insights into the Clinical Studies, Emerging Therapies, and Treatment Algorithm | Companies - Caladrius, Angionetics, Imbria Pharmaceuticals, XyloCor

Source :
M2 Presswire. April 5, 2022
Publication Year :
2022

Abstract

M2 PRESSWIRE-April 5, 2022-: Refractory Angina Pipeline Analysis Report 2022 - Insights into the Clinical Studies, Emerging Therapies, and Treatment Algorithm | Companies - Caladrius, Angionetics, Imbria Pharmaceuticals, XyloCor (C)1994-2022 [...]

Subjects

Subjects :
Pipe lines -- Reports
Business -- Research
Medical research -- Reports
Medicine, Experimental -- Reports
Angina pectoris -- Care and treatment
Clinical trials -- Reports
Algorithms -- Reports
Algorithm
Business
Business, international

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Presswire
Publication Type :
News
Accession number :
edsgcl.699381981

Tools

Authors Abstract Subjects Details